Clinical Trial Update: Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1) [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase study assessing the safety and potential efficacy of a single suprachoroidal injection of JWK010 gene therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oculocutaneous Albinism Type

Drugs mentioned

• JWK010 gene therapy

Snippet

Sponsor: West China Hospital | Conditions: Oculocutaneous Albinism (OCA) | EARLY_Phase 1 | Status: RECRUITING